imdevimab: Clinical Trials

2 trials of imdevimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2
Phase 21Terminated 1

Follow imdevimab: new trials by email Literature Review of imdevimab trials Research Report on imdevimab

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19
casirivimab+imdevimab - COVID-19
Phase 1TerminatedRegeneron Pharmaceuticals22021-12-162025-10-14
COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease
REGN14256, imdevimab, casirivimab + imdevimab - SARS-CoV-2
Phase 1 / Phase 2TerminatedRegeneron Pharmaceuticals252021-11-082025-10-28

Conditions studied

COVID-19 (2)  ·  Coronavirus Infections (2)

Sponsors

Regeneron Pharmaceuticals (2)

Countries

United States (2)